Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dyadic International, Inc. - Common Stock (NQ:DYAI)

1.110 +0.010 (+0.91%)
Streaming Delayed Price Updated: 10:02 AM EDT, Sep 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dyadic International, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Dyadic Announces Change in Board and Management Leadership Roles
From Dyadic International, Inc.
Via GlobeNewswire
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
Via AB Newswire
Topics Initial Public Offering
Dyadic International, Inc. (NASDAQ: DYAI) on “The Street Podcast” and Featured in Prestigious Science and Technology Journal – Tune In and Dive In!
Via AB Newswire
Dyadic International's Earnings: A Preview
 
Via Benzinga
Dyadic International Inc. (NASDAQ: DYAI): A Value Play Gaining Investor Attention
Via AB Newswire
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
Dyadic to Attend Industry Events in April
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
Via AB Newswire
Topics Supply Chain
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
Via AB Newswire
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
From Dyadic International, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
From Dyadic International, Inc.
Via GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Biotech Breakthroughs: Dyadic International (NASDAQ: DYAI) Partners with Rabian BV to Combat Rabies
Via AB Newswire
Topics Death
Dyadic to Attend Industry Events in March
From Dyadic International, Inc.
Via GlobeNewswire
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
Via AB Newswire
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
From Dyadic International, Inc.
Via GlobeNewswire
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Dyadic International Inc. (NASDAQ: DYAI) Surges 19.2% Amid Robust Trading Volume Following Expanded Collaboration with Israeli Institutes
Via AB Newswire
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
From Dyadic International, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
Via AB Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies
Via AB Newswire
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
From Dyadic International, Inc.
Via GlobeNewswire
Breaking Ground in BioPharma: Spotlight Companies DYAI, INBS, SANA, IOVA, BLUE
Via AB Newswire
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
From Dyadic International, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.